ImmunoGen
IMGN
#2213
Rank
A$12.74 B
Marketcap
A$45.64
Share price
0.00%
Change (1 day)
123.38%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -A$90.32 Million

According to ImmunoGen 's latest financial reports the company's current earnings are A$0.28 Billion. In 2022 the company made an earning of -A$0.32 Billion a decrease over its 2021 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$90.32 Million-71.59%
2022 -A$0.32 Billion72.45%
2021 -A$0.19 Billion495.9%
2020 -A$30.94 Million-75.71%
2019 -A$0.13 Billion-44.88%
2018 -A$0.24 Billion99.42%
2017 -A$0.12 Billion
2015 -A$0.16 Billion43.7%
2014 -A$0.11 Billion135.39%
2013 -A$45.07 Million-66.03%
2012 -A$0.14 Billion42.86%
2011 -A$92.85 Million16.68%
2010 -A$79.58 Million32.83%
2009 -A$59.92 Million-1.99%
2008 -A$61.13 Million108.61%
2007 -A$29.31 Million-10.13%
2006 -A$32.61 Million28.86%
2005 -A$25.31 Million120.33%
2004 -A$11.49 Million-61.19%
2003 -A$29.59 Million-16.6%
2002 -A$35.48 Million51.86%
2001 -A$23.37 Million
1999 A$1.31 M-112.68%
1998 -A$10.38 Million-13.41%
1997 -A$11.99 Million-10.87%
1996 -A$13.45 Million-35.66%
1995 -A$20.9 Million-19.21%
1994 -A$25.87 Million-14.49%
1993 -A$30.25 Million23.95%
1992 -A$24.41 Million
1989 -A$10.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.35 B-29,920.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.47 B-20,238.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.18 B-11,199.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.80 B-55,483.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.15 B-17,704.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.38 B-12,505.47%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$16.55 B-18,150.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.16 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA